SCHEMBL4372010

SCHEMBL4372010

CC(C)(C)N(C(=O)O)c1ccccc1C(=O)Nc1ccc(Nc2cc(-c3cccc4c3oc3ccccc34)ncn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP4K2C Q8TBX8 2/20 0.40
CYP1A2 P05177 5/20 0.37
CYP2D6 P10635 4/20 0.37
CYP2C19 P33261 3/20 0.37
CLK4 Q9HAZ1 3/20 0.37
CYP3A4 P08684 2/20 0.37
MAPK1 P28482 2/20 0.37
ALDH1A1 P00352 2/20 0.37
TSHR P16473 2/20 0.37
CCNT1 O60563 7/20 0.37
CDK9 P50750 7/20 0.37
PIP4K2A P48426 3/20 0.36
PIP4K2B P78356 3/20 0.36
PIKFYVE Q9Y2I7 1/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 3/20 0.35
CYP2C9 P11712 1/20 0.35
USP2 O75604 2/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4377531 0.95 PIP4K2C (0.42) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL28527047 0.92 CCNT1 (0.39) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL1243768 0.89 PIP4K2C (0.42) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL4375143 0.88 PIP4K2C (0.43) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL1244508 0.85 CCNT1 (0.39) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL4378384 0.83 RET (0.38) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL4375779 0.83 PIP4K2C (0.50) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL1244273 0.83 PIP4K2C (0.43) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL1244828 0.83 PIP4K2C (0.42) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4
SCHEMBL1243893 0.82 PIP4K2C (0.51) PIP4K2CCYP1A2CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763526-B1 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AG (DE) 2009-06-24 EP claimed